PHASE-II TRIAL OF 13-CIS-RETINOIC ACID PLUS INTERFERON-ALPHA IN NON-SMALL-CELL LUNG-CANCER

被引：26

作者：

ARNOLD, A

AYOUB, J

DOUGLAS, L

HOOGENDOORN, P

SKINGLEY, L

GELMON, K

HIRSH, V

EISENHAUER, E

机构：

[1] HAMILTON REG CANC CTR,DEPT CLIN TRIALS,HAMILTON,ON,CANADA

[2] HOP NOTRE DAME DE BON SECOURS,CTR ONCOL,MONTREAL H2L 4K8,QUEBEC,CANADA

[3] NATL CANC INST CANADA,CLIN TRIALS GRP,INVEST NEW DRUG PROGRAMME,KINGSTON,ON,CANADA

[4] HOFFMAN LA ROCHE,DEPT INT CLIN RES,MISSISSAUGA,ON,CANADA

[5] BRITISH COLUMBIA CANC AGCY,DEPT MED ONCOL,VANCOUVER,BC,CANADA

[6] SANTA CABRINI HOSP,DEPT HEMATOL,MONTREAL,PQ,CANADA

来源：

JOURNAL OF THE NATIONAL CANCER INSTITUTE | 1994年 / 86卷 / 04期

关键词：

D O I：

10.1093/jnci/86.4.306

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

[No abstract available]

引用

页码：306 / 309

页数：4

共 13 条

[1] RETINOIDS IN CANCER PREVENTION AND THERAPY [J].

BOLLAG, W ;

HOLDENER, EE .

ANNALS OF ONCOLOGY, 1992, 3 (07) :513-526

[2] CANCER STATISTICS, 1992 [J].

BORING, CC ;

SQUIRES, TS ;

TONG, T .

CA-A CANCER JOURNAL FOR CLINICIANS, 1992, 42 (01) :19-38

[3]

DHINGRA K, 1993, NEW DRUGS, V11, P39

[4] ANTIPROLIFERATIVE ACTIVITY OF RETINOIDS, INTERFERON ALPHA AND THEIR COMBINATION IN 5 HUMAN TRANSFORMED-CELL LINES [J].

FREY, JR ;

PECK, R ;

BOLLAG, W .

CANCER LETTERS, 1991, 57 (03) :223-227

[5]

JOHNSON DH, 1990, SEMIN ONCOL, V17, P20

[6] 13-CIS-RETINOIC ACID PLUS INTERFERON-ALPHA-2A IN LOCALLY ADVANCED SQUAMOUS-CELL CARCINOMA OF THE CERVIX [J].

LIPPMAN, SM ;

KAVANAGH, JJ ;

PAREDESESPINOZA, M ;

DELGADILLOMADRUENO, F ;

PAREDESCASILLAS, P ;

HONG, WK ;

MASSIMINI, G ;

HOLDENER, EE ;

KRAKOFF, IH .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (06) :499-500

[7] 13-CIS-RETINOIC ACID AND INTERFERON ALPHA-2A - EFFECTIVE COMBINATION THERAPY FOR ADVANCED SQUAMOUS-CELL CARCINOMA OF THE SKIN [J].

LIPPMAN, SM ;

PARKINSON, DR ;

ITRI, LM ;

WEBER, RS ;

SCHANTZ, SP ;

OTA, DM ;

SCHUSTERMAN, MA ;

KRAKOFF, IH ;

GUTTERMAN, JU ;

HONG, WK .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (04) :235-241

[8] 13-CIS-RETINOIC ACID PLUS INTERFERON ALPHA-2A - HIGHLY-ACTIVE SYSTEMIC THERAPY FOR SQUAMOUS-CELL CARCINOMA OF THE CERVIX [J].

LIPPMAN, SM ;

KAVANAGH, JJ ;

PAREDESESPINOZA, M ;

DELGADILLOMADRUENO, F ;

PAREDESCASILLAS, P ;

HONG, WK ;

HOLDENER, E ;

KRAKOFF, IH .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1992, 84 (04) :241-245

[9]

MOUNTAIN CF, 1979, AM JOINT COMMITTEE C

[10] CHEMOTHERAPY CAN PROLONG SURVIVAL IN PATIENTS WITH ADVANCED NON-SMALL-CELL LUNG-CANCER - REPORT OF A CANADIAN MULTICENTER RANDOMIZED TRIAL [J].

RAPP, E ;

PATER, JL ;

WILLAN, A ;

CORMIER, Y ;

MURRAY, N ;

EVANS, WK ;

HODSON, DI ;

CLARK, DA ;

FELD, R ;

ARNOLD, AM ;

AYOUB, JI ;

WILSON, KS ;

LATREILLE, J ;

WIERZBICKI, RF ;

HILL, DP .

JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (04) :633-641

← 1 2 →